Form 4 for VRDN Viridian Therapeutics, Inc.\DE
Accepted 2025-10-27 00:00:00 ET · period of report 2025-10-23 · accession 0001104659-25-102606 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-10-27 | 2025-10-23 | VRDN | Fairmount Healthcare Fund II GP LLC | Dir, 10% | P - Purchase | $22.00 | +454.5K | 3.91M | +13% | +$10.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-23 | P | A | 454,545 | $22.00 | 3,914,458 | I Fairmount Healthcare Fund II LP | — | — | (F1) Fairmount Funds Management LLC ("Fairmount") and Fairmount Healthcare Fund II GP LLC ("Fairmount GP II") have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein. |